NEW YORK (GenomeWeb) – Illumina reported after the close of the market Monday that its third quarter revenues climbed 35 percent year over year, as the firm easily beat Wall Street estimates on the top and bottom lines.

The San Diego-based genetic analysis products firm brought in total revenues of $480.6 million for the three months ended Sept. 28, compared to $356.8 million for the third quarter of 2013. Analysts, on average, had expected total revenues of $451.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.